Bähr, O., Tabatabai, G., Fietkau, R., Goldbrunner, R., & Glas, M. (2018). P01.095 The use of TTFields for newly diagnosed GBM patients in Germany in routine clinical care (TIGER: TTFields in Germany in routine clinical care). Neuro Oncol.
Chicago ZitierstilBähr, O., G. Tabatabai, R. Fietkau, R. Goldbrunner, und M. Glas. "P01.095 The Use of TTFields for Newly Diagnosed GBM Patients in Germany in Routine Clinical Care (TIGER: TTFields in Germany in Routine Clinical Care)." Neuro Oncol 2018.
MLA ZitierstilBähr, O., et al. "P01.095 The Use of TTFields for Newly Diagnosed GBM Patients in Germany in Routine Clinical Care (TIGER: TTFields in Germany in Routine Clinical Care)." Neuro Oncol 2018.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.